India’s Sun Pharma Recalls Diabetes Drug From U.S. After Seizure Drug Found In Bottle
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries said it was recalling from the U.S. market 2,528 bottles of its Glumetza (metformin) diabetes drug after tablets of another drug, gabapentin for treating seizures, was found in one bottle.